| Betterchem |

|
|
| FDA approval activities
for this prescription drug:
EVOXAC (cevimeline HCl) Capsules, 30 mg, SnowBrand NDA 20-989 1/11/00 1/19/00 1/19/00 3/12/02 EVOXAC Indication: for the treatment of symptoms of dry mouth in patients with Sjogren's Syndrome. |
|
© 2009 Betterchem.com
|